Biomarin Pharmaceutical Balance Sheet (2009-2026)

Reported Financials

Biomarin Pharmaceutical Quarterly Balance Sheet

Periods 69 quarters

Latest Jun 2026

Biomarin Pharmaceutical reported total assets of $11.72B and total liabilities of $5.40B for the quarter ended Jun 2026, up 57.2% year over year. This balance sheet covers 69 quarters of results from Jun 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	0.62B	0.59B	0.61B	0.62B	0.76B	0.72B	0.58B	0.69B	0.79B	0.76B	0.75B	0.97B	0.68B	0.94B	1.05B	1.21B	1.25B	1.31B	2.22B	0.87B
Short-term InvestmentsInvestments (Current)	0.46B	0.43B	0.45B	0.49B	0.51B	0.57B	0.57B	0.48B	0.34B	0.32B	0.30B	0.25B	0.25B	0.19B	0.22B	0.22B	0.23B	0.25B
Cash & Current Investments	1.08B	1.01B	1.06B	1.11B	1.27B	1.29B	1.15B	1.17B	1.13B	1.07B	1.05B	1.22B	0.93B	1.14B	1.27B	1.43B	1.48B	1.56B	2.22B	0.87B
Receivables - NetNet Receivables	0.37B	0.37B	0.43B	0.47B	0.42B	0.46B	0.60B	0.61B	0.57B	0.63B	0.64B	0.69B	0.78B	0.66B	0.74B	0.86B	0.79B	0.91B	0.90B	1.06B
Receivables - OtherOther Receivables
Receivables	0.37B	0.37B	0.43B	0.47B	0.42B	0.46B	0.60B	0.61B	0.57B	0.63B	0.64B	0.69B	0.78B	0.66B	0.74B	0.86B	0.79B	0.91B	0.90B	1.06B
Raw Materials	0.08B
Work In Process	0.41B
Finished Goods	0.26B
Inventory	0.75B	0.78B	0.79B	0.80B	0.84B	0.89B	0.92B	0.98B	1.03B	1.11B	1.14B	1.18B	1.18B	1.23B	1.27B	1.34B	1.38B	1.30B	1.27B	1.78B
Current Deferred Tax AssetsCurrent Deferred Tax
Prepaid Assets	0.11B	0.11B	0.12B	0.14B	0.15B	0.10B	0.17B	0.19B	0.22B	0.14B	0.16B	0.16B	0.17B	0.20B	0.18B	0.18B	0.20B	0.19B	0.21B	0.25B
Current Assets	2.31B	2.27B	2.39B	2.52B	2.68B	2.75B	2.84B	2.95B	2.96B	2.96B	2.99B	3.26B	3.06B	3.23B	3.47B	3.81B	3.85B	3.95B	4.61B	3.97B
Non-Current Assets
Buildings
Construction in Progress
Land & Improvements
Property, Plant & Equipment (Net)PP&E (Net)	1.02B	1.04B	1.04B	1.05B	1.05B	1.07B	1.07B	1.07B	1.07B	1.07B	1.06B	1.05B	1.05B	1.04B	1.03B	1.03B	1.04B	0.95B	0.96B	0.99B
Long-Term Investments	0.47B	0.51B	0.46B	0.41B	0.37B	0.33B	0.34B	0.39B	0.55B	0.61B	0.62B	0.56B	0.56B	0.52B	0.51B	0.51B	0.51B	0.49B
Goodwill	0.20B	0.20B	0.20B	0.20B	0.20B	0.20B	0.20B	0.20B	0.20B	0.20B	0.20B	0.20B	0.20B	0.20B	0.20B	0.20B	0.20B	0.20B	0.20B	0.66B
Intangibles	0.39B	0.39B	0.37B	0.37B	0.35B	0.34B	0.33B	0.31B	0.30B	0.29B	0.28B	0.27B	0.26B	0.26B	0.25B	0.24B	0.23B	0.21B	0.20B	4.88B
Goodwill & Intangibles	0.58B	0.58B	0.57B	0.57B	0.55B	0.53B	0.52B	0.51B	0.50B	0.49B	0.48B	0.46B	0.46B	0.45B	0.44B	0.44B	0.43B	0.41B	0.40B	5.54B
Long-Term Deferred Tax	1.45B	1.45B	1.45B	1.45B	1.46B	1.51B	1.51B	1.51B	1.52B	1.55B	1.55B	1.55B	1.53B	1.49B	1.46B	1.43B	1.51B	1.51B	1.50B	0.89B
Other Non-Current Assets	0.14B	0.15B	0.15B	0.15B	0.15B	0.18B	0.15B	0.14B	0.17B	0.17B	0.18B	0.19B	0.20B	0.25B	0.24B	0.25B	0.27B	0.28B	0.85B	0.34B
Non-Current Assets	3.67B	3.73B	3.67B	3.63B	3.58B	3.62B	3.59B	3.61B	3.80B	3.89B	3.89B	3.81B	3.79B	3.76B	3.68B	3.65B	3.76B	3.64B	3.99B	7.75B
Assets	5.98B	6.00B	6.06B	6.15B	6.26B	6.38B	6.43B	6.56B	6.76B	6.84B	6.87B	7.07B	6.85B	6.99B	7.15B	7.46B	7.61B	7.59B	8.59B	11.72B
Liabilities
Current Liabilities
Accounts Payables	0.47B	0.50B	0.43B	0.43B	0.49B	0.57B	0.60B	0.60B	0.67B	0.68B	0.59B	0.57B	0.72B	0.61B	0.63B	0.68B	0.80B	0.76B	0.79B	1.01B
Notes Payables
Payables	0.47B	0.50B	0.43B	0.43B	0.49B	0.57B	0.60B	0.60B	0.67B	0.68B	0.59B	0.57B	0.72B	0.61B	0.63B	0.68B	0.80B	0.76B	0.79B	1.01B
Accumulated Expenses
Other Accumulated Expenses
Short term Debt	0.05B	0.05B	0.06B	0.03B	0.03B	0.02B			0.49B	0.49B	0.49B	0.49B								0.66B
Current Taxes
Current Deferred Revenue
Total Current Liabilities	0.51B	0.55B	0.49B	0.46B	0.52B	0.59B	0.60B	0.60B	1.16B	1.18B	1.09B	1.07B	0.72B	0.61B	0.63B	0.68B	0.80B	0.76B	0.79B	1.66B
Non-Current Liabilities
Non-Current Debt																		0.60B	1.43B	4.19B
Convertible Debt	1.08B	1.08B	1.08B	1.08B	1.08B	1.08B	1.08B	1.08B	1.09B	1.09B	1.09B	1.09B	0.59B	0.60B	0.60B	0.60B	0.60B	0.60B
Non-Current Deffered Revenue
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
Other Non-Current Liabilities	0.10B	0.10B	0.10B	0.10B	0.09B	0.10B	0.09B	0.10B	0.11B	0.12B	0.12B	0.12B	0.13B	0.13B	0.13B	0.15B	0.16B	0.15B	0.16B	0.21B
Total Non-Current Liabilities	1.61B	1.64B	1.57B	1.55B	1.60B	1.67B	1.68B	1.68B	1.76B	1.77B	1.68B	1.66B	1.31B	1.20B	1.22B	1.28B	1.40B	1.36B	2.22B	5.19B
Total Liabilities	1.71B	1.74B	1.67B	1.64B	1.70B	1.77B	1.77B	1.78B	1.86B	1.89B	1.80B	1.78B	1.44B	1.33B	1.35B	1.43B	1.56B	1.51B	2.38B	5.40B
Shareholder's Equity
Total Debt	0.05B	0.05B	0.06B	0.03B	0.03B	0.02B			0.49B	0.49B	0.49B	0.49B						0.60B	1.43B	4.84B
Common Equity	4.26B	4.27B	4.39B	4.50B	4.57B	4.60B	4.66B	4.78B	4.90B	4.95B	5.07B	5.29B	5.41B	5.66B	5.79B	6.03B	6.06B	6.09B	6.21B	6.32B
Liabilities and Shareholders Equity	5.98B	6.00B	6.06B	6.15B	6.26B	6.38B	6.43B	6.56B	6.76B	6.84B	6.87B	7.07B	6.85B	6.99B	7.15B	7.46B	7.61B	7.59B	8.59B	11.72B
Retained Earnings	-0.87B	-0.93B	-0.80B	-0.78B	-0.79B	-0.79B	-0.74B	-0.68B	-0.64B	-0.62B	-0.53B	-0.43B	-0.32B	-0.19B	0.02B	0.23B	0.20B	0.15B	0.26B	0.30B

Biomarin Pharmaceutical BMRN Balance Sheet (2009-2026)

Biomarin Pharmaceutical Quarterly Balance Sheet

Create an account

Sign In

Reset Password